Phospha E linked to healthy cardiovascular function
Friday, 21 October, 2005
Melbourne's Phosphagenics (ASX:POH) has found its vitamin product Phospha E has reduced LDL-C (bad cholesterol) concentrations in blood by up to 44 per cent in an animal study.
"Based on these animal studies, as well as earlier in vitro studies, we are confident in the potential of Phospha E to support cardiovascular health in humans," said Phosphagenics director of research and development Esra Ogru in a statement. "Phosphagenics intends to commence clinical trials in humans to provide further support for the product's health benefits, including its effect on cardiovascular health."
Phospha E was also found to reduce another heart disease risk factor, plasma triglycerides, by up to 51 per cent in mice fed normal diets. When fed high cholesterol diets, Phospha E significantly reduced plaque formation in the aorta by 58 per cent. In contrast, regular vitamin E had no significant effect on plaque formation, or cholesterol levels.
Heart valve tissues created from stem cells
The breakthrough should help advance our understanding into how human heart valves develop,...
Breast augmentation procedure uses 3D-printed scaffolds
3D-printed scaffold technology from medtech company BellaSeno has been used in a primary breast...
Victoria detects H5N1 avian influenza strain
It follows disease confirmation in seabirds in WA, SA, NSW and Qld and the national decision that...
